Your browser doesn't support javascript.
loading
QFR-Based Virtual PCI or Conventional Angiography to Guide PCI: The AQVA Trial.
Biscaglia, Simone; Verardi, Filippo Maria; Tebaldi, Matteo; Guiducci, Vincenzo; Caglioni, Serena; Campana, Roberta; Scala, Antonella; Marrone, Andrea; Pompei, Graziella; Marchini, Federico; Scancarello, Davide; Pignatelli, Gianluca; D'Amore, Sergio Musto; Colaiori, Iginio; Demola, Pierluigi; Di Serafino, Luigi; Tumscitz, Carlo; Penzo, Carlo; Erriquez, Andrea; Manfrini, Marco; Campo, Gianluca.
Affiliation
  • Biscaglia S; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona, Ferrara, Italy. Electronic address: bscsmn@unife.it.
  • Verardi FM; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona, Ferrara, Italy.
  • Tebaldi M; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona, Ferrara, Italy.
  • Guiducci V; Cardiology Unit, Azienda Unità Sanitaria Locale, Istituti di Ricovero e Cura a Carattere Scientifico, Istituto in Tecnologie Avanzate e Modelli Assistenziali di Reggio Emilia, Reggio Emilia, Italy.
  • Caglioni S; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona, Ferrara, Italy.
  • Campana R; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona, Ferrara, Italy.
  • Scala A; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona, Ferrara, Italy.
  • Marrone A; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona, Ferrara, Italy.
  • Pompei G; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona, Ferrara, Italy.
  • Marchini F; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona, Ferrara, Italy.
  • Scancarello D; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona, Ferrara, Italy.
  • Pignatelli G; Cardiology Unit, Azienda Unità Sanitaria Locale, Istituti di Ricovero e Cura a Carattere Scientifico, Istituto in Tecnologie Avanzate e Modelli Assistenziali di Reggio Emilia, Reggio Emilia, Italy.
  • D'Amore SM; Cardiology Unit, Azienda Unità Sanitaria Locale, Istituti di Ricovero e Cura a Carattere Scientifico, Istituto in Tecnologie Avanzate e Modelli Assistenziali di Reggio Emilia, Reggio Emilia, Italy.
  • Colaiori I; Cardiology Unit, Azienda Unità Sanitaria Locale, Istituti di Ricovero e Cura a Carattere Scientifico, Istituto in Tecnologie Avanzate e Modelli Assistenziali di Reggio Emilia, Reggio Emilia, Italy.
  • Demola P; Cardiology Unit, Azienda Unità Sanitaria Locale, Istituti di Ricovero e Cura a Carattere Scientifico, Istituto in Tecnologie Avanzate e Modelli Assistenziali di Reggio Emilia, Reggio Emilia, Italy.
  • Di Serafino L; Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.
  • Tumscitz C; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona, Ferrara, Italy.
  • Penzo C; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona, Ferrara, Italy.
  • Erriquez A; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona, Ferrara, Italy.
  • Manfrini M; Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Cotignola, Ravenna, Italy.
  • Campo G; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona, Ferrara, Italy.
JACC Cardiovasc Interv ; 16(7): 783-794, 2023 04 10.
Article de En | MEDLINE | ID: mdl-36898939
ABSTRACT

BACKGROUND:

Post-percutaneous coronary intervention (PCI) quantitative flow ratio (QFR) values ≥0.90 are associated with a low incidence of adverse events.

OBJECTIVES:

The AQVA (Angio-based Quantitative Flow Ratio Virtual PCI Versus Conventional Angio-guided PCI in the Achievement of an Optimal Post-PCI QFR) trial aims to test whether a QFR-based virtual percutaneous coronary intervention (PCI) is superior to a conventional angiography-based PCI at obtaining optimal post-PCI QFR results.

METHODS:

The AQVA trial is an investigator-initiated, randomized, controlled, parallel-group clinical trial. A total of 300 patients (356 study vessels) undergoing PCI were randomized 11 to receive either QFR-based virtual PCI or angiography-based PCI (standard of care). The primary outcome was the rate of study vessels with a suboptimal post-PCI QFR value, which was defined as <0.90. Secondary outcomes were procedure duration, stent length/lesion, and stent number/patient.

RESULTS:

Overall, 38 (10.7%) study vessels missed the prespecified optimal post-PCI QFR target. The primary outcome occurred significantly more frequently in the angiography-based group (n = 26, 15.1%) compared with the QFR-based virtual PCI group (n = 12 [6.6%]; absolute difference = 8.5%; relative difference = 57%; P = 0.009). The main cause of a suboptimal result in the angiography-based group is the underestimation of a diseased segment outside the stented one. There were no significant differences among secondary endpoints, although stent length/lesion and stent number/patient were numerically lower in the virtual PCI group (P = 0.06 and P = 0.08, respectively), whereas procedure length was higher in the virtual PCI group (P = 0.06).

CONCLUSIONS:

The AQVA trial demonstrated the superiority of QFR-based virtual PCI over angiography-based PCI with regard to post-PCI optimal physiological results. Future larger randomized clinical trials that demonstrate the superiority of this approach in terms of clinical outcomes are warranted. (Angio-based Quantitative Flow Ratio Virtual PCI Versus Conventional Angio-guided PCI in the Achievement of an Optimal Post-PCI QFR [AQVA]; NCT04664140).
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie des artères coronaires / Fraction du flux de réserve coronaire / Intervention coronarienne percutanée Type d'étude: Clinical_trials / Etiology_studies / Prognostic_studies Limites: Humans Langue: En Journal: JACC Cardiovasc Interv Sujet du journal: ANGIOLOGIA / CARDIOLOGIA Année: 2023 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie des artères coronaires / Fraction du flux de réserve coronaire / Intervention coronarienne percutanée Type d'étude: Clinical_trials / Etiology_studies / Prognostic_studies Limites: Humans Langue: En Journal: JACC Cardiovasc Interv Sujet du journal: ANGIOLOGIA / CARDIOLOGIA Année: 2023 Type de document: Article